These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14623020)

  • 21. Recombinant derivative of a naturally occurring non-toxinogenic Vibrio cholerae 01 expressing the B subunit of cholera toxin: a potential oral vaccine strain.
    Dasgupta U; Bhadra RK; Panda DK; Deb A; Das J
    Vaccine; 1994 Mar; 12(4):359-64. PubMed ID: 8178559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current developments with cholera vaccines: "Where do we go from here?".
    Finkelstein RA
    Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372
    [No Abstract]   [Full Text] [Related]  

  • 24. Vibrio cholerae and cholera: out of the water and into the host.
    Reidl J; Klose KE
    FEMS Microbiol Rev; 2002 Jun; 26(2):125-39. PubMed ID: 12069878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholera: recent updates.
    Weil AA; Ryan ET
    Curr Opin Infect Dis; 2018 Oct; 31(5):455-461. PubMed ID: 30048254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection.
    Queen J; Satchell KJ
    Infect Immun; 2012 Aug; 80(8):2905-13. PubMed ID: 22615254
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Weil AA; Becker RL; Harris JB
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776240
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins.
    Rui H; Ritchie JM; Bronson RT; Mekalanos JJ; Zhang Y; Waldor MK
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4359-64. PubMed ID: 20160087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.
    Bishop AL; Patimalla B; Camilli A
    Infect Immun; 2014 Jun; 82(6):2434-47. PubMed ID: 24686062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 33. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An oral cholera vaccine for travelers (Vaxchora).
    Med Lett Drugs Ther; 2016 Aug; 58(1502):113-4. PubMed ID: 27552209
    [No Abstract]   [Full Text] [Related]  

  • 36. Colonization & protection in infant rabbits by a choleragenoid producing strain of Vibrio cholerae.
    Sinha VB; Srivastava BS
    Indian J Med Res; 1986 Aug; 84():139-41. PubMed ID: 3759164
    [No Abstract]   [Full Text] [Related]  

  • 37. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholera research 100 years after its discovery--current topics].
    Zinnaka Y
    Nihon Saikingaku Zasshi; 1984 Jul; 39(4):713-31. PubMed ID: 6094878
    [No Abstract]   [Full Text] [Related]  

  • 39. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.
    Albert MJ; Alam K; Ansaruzzaman M; Qadri F; Sack RB
    J Infect Dis; 1994 Jan; 169(1):230-1. PubMed ID: 8277193
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholera vaccines.
    Ryan ET; Calderwood SB
    Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.